Investments

ATRO Medical has reached a milestone in the clinical evaluation of its latest Artimis Meniscus Prosthesis design....

The company’s vision is to provide the first credible replacement for metal implants in the global orthopedic fixation market....

Entirety is developing magnesium implants designed to deliver the strength and handling characteristics of traditional titanium implants....

Funds will support development of 3D-printed implant systems that introduce architectures tailored to real surgical workflows....

The infusion will accelerate a Phase III trial of investigational mesenchymal stem cell therapy to treat cartilage defects in patients...

Proceeds of the revolver will support general corporate purposes as Advita expands sales of its portfolio of established product lines....

Funds will support a first in-human clinical study in Canada, as well as R&D and a future pivotal trial of...

The company gained Chinese regulatory approval for a $10 million strategic equity investment by a subsidiary of WEGO Orthopaedics....

With the completion of this refinancing, the company now has total liquidity of approximately $165 million....

The company is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or...